Suppression of hypoxia inducible factor-1α (HIF-1α) by YC-1 is dependent on murine double minute 2 (Mdm2)
Authors:
Open Access
- 1 October 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 348 (4) , 1443-1448
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- An expanding role for mTOR in cancerTrends in Molecular Medicine, 2005
- Expression of Hypoxia-Inducible Factor-1α Protein Predicts Survival in Patients with Transitional Cell Carcinoma of the Upper Urinary TractClinical Cancer Research, 2005
- Hypoxia‐inducible factor‐1α is associated with angiogenesis, and expression of bFGF, PDGF‐BB, and EGFR in invasive breast cancerHistopathology, 2005
- Dysregulation of the TSC-mTOR pathway in human diseaseNature Genetics, 2004
- Direct transcriptional regulation of MDM2 by Fli-1Oncogene, 2004
- Role of Hypoxia-Inducible Factor 1 in Gastric Cancer Cell Growth, Angiogenesis, and Vessel MaturationJNCI: Journal of the National Cancer Institute, 2004
- Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor-1α and its significanceJournal of Hepatology, 2004
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Regulation of the multidrug resistance transporter P‐glycoprotein in multicellular tumor spheroids by hypoxia‐inducible factor‐1 and reactive oxygen speciesThe FASEB Journal, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002